EUVIMEDEUVIMED entdecken
Übersichtsarbeit

IL-1β+ macrophages and the control of pathogenic inflammation in cancer

Nicoletta Caronni, Federica La Terza, Luca Frosio, Renato Ostuni

Trends in Immunology · 2025-05 · 46 (5) · 403-415

DOI: 10.1016/j.it.2025.03.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2025-05. Verfasst von Nicoletta Caronni und 3 weiteren Autor:innen. Beteiligte Einrichtung: San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: caronni.nicol…. Hauptthemen laut MEDLINE: Neoplasms, Interleukin-1beta, Inflammation, Macrophages. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 128 Literaturangaben. Gefördert von: European Research Council, Telethon Foundation, Fondazione AIRC per la ricerca sul cancro ETS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While highlighting the complexity and heterogeneity of tumor immune microenvironments, the application of single-cell analyses in human cancers has identified recurrent subsets of tumor-associated macrophages (TAMs). Among these, interleukin (IL)-1β+ TAMs - cells with high levels of expression of inflammatory response and tissue repair genes, but with limited capacity to stimulate cytotoxic immunity - are emerging as key drivers of pathogenic inflammation in cancer. In this review we discuss recent literature defining the phenotypical, molecular, and functional properties of IL-1β+ TAMs, as well as their temporal dynamics and spatial organization. Elucidating the biology of these cells across tumor initiation, progression, metastasis, and therapy could inform the design and interpretation of clinical trials targeting IL-1β and/or other inflammatory factors in cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsInterleukin-1betaInflammationMacrophagesTumor-Associated MacrophagesHumansAnimalsTumor Microenvironment

Stichwörter der Autor:innen

cancerinflammationinterleukin 1macrophagestumor microenvironment

Substanzen

Interleukin-1beta

Autor:innen und Institutionen

  • San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: caronni.nicoletta@hsr.it.
  • San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic…

Förderung

  • European Research Council
  • Telethon Foundation
  • Fondazione AIRC per la ricerca sul cancro ETS
  • American Association for Cancer Research
  • Ministry of Health
  • Fondazione Umberto Veronesi
  • FP7 Ideas: European Research Council
  • Associazione Italiana per la Ricerca sul Cancro

Zitieren

APA

Caronni, N., La Terza, F., Frosio, L., & Ostuni, R. (2025). IL-1β+ macrophages and the control of pathogenic inflammation in cancer. Trends in Immunology, 46(5), 403-415. https://doi.org/10.1016/j.it.2025.03.001

Vancouver

Caronni N, La Terza F, Frosio L, Ostuni R. IL-1β+ macrophages and the control of pathogenic inflammation in cancer. Trends in Immunology. 2025;46(5):403-415. doi:10.1016/j.it.2025.03.001

BibTeX
@article{Caronni2025,
  author = {Caronni, Nicoletta and La Terza, Federica and Frosio, Luca and Ostuni, Renato},
  title = {IL-1β+ macrophages and the control of pathogenic inflammation in cancer},
  journal = {Trends in Immunology},
  year = {2025},
  volume = {46},
  number = {5},
  pages = {403--415},
  doi = {10.1016/j.it.2025.03.001}
}
Kostenlos starten →